Episode Summary
Prepare to challenge assumptions about “Big Pharma” and clinical trials. Celerion Executive Director Angie Badgett offers a fresh perspective on marketing clinical research studies to the public. Angie discusses translating scientific terms, infusing regulatory compliance with creativity, and humanizing the pharmaceutical industry. Tune in to learn why you shouldn’t believe everything you see on Netflix, and what it takes to build a reputable brand with real customer relationships.
Key Takeaways
- We explore key challenges and solutions when it comes to working with marketers and creatives in highly regulated industries.
- Didn’t expect a clinical research organization to be on TikTok? Angie explains why social and word-of-mouth marketing are instrumental to Celerion’s success.
- As a 19-year Celerion veteran, Angie discusses what it takes for a company to create a culture of employee loyalty and long-term satisfaction.
- We learn about the four levels of conversion that Angie and her team use to measure the impact of their marketing initiatives.
About Angie Badgett
Executive Director, Global Project Management and Strategic Solutions, Celerion
Angie Badgett serves as the Executive Director of Global Project Management and Strategic Solutions at Celerion, a leading clinical research organization dedicated to testing and supporting the development of new medicines in collaboration with pharmaceutical companies. With a tenure spanning back to 2006, Angie has played a pivotal role in the growth and success of Celerion, rising through the ranks with a series of progressively responsible positions. Her adept management skills are evident in her oversight of a team of department heads, ensuring seamless coordination and driving consistent revenue growth.
We definitely have TikTok accounts. We've got creative people who have balanced brains where they can follow all of the requirements from a regulatory standpoint but then figure out how to…get content out there for people to understand what we do at our facility.